Skip to main content
. 2021 Feb 20;13(4):889. doi: 10.3390/cancers13040889

Figure 5.

Figure 5

Current WNT/β-catenin inhibitors being used in combination with ICI for human clinical trial. (Adapted from “Wnt//β-catenin signaling”, by BioRender.com (2020). Retrieved from https://app.biorender.com/biorender-templates).